Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Irinotecan and Gemcitabine (IrinoGem) Combined With 3-D Conformal Radiation Therapy for Locally Advanced Pancreatic Cancer

NCT00192712 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT00192712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00192712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Irinotecan and Gemcitabine (IrinoGem) Combined With 3-D Conformal Radiation Therapy for Locally Advanced Pancreatic Cancer
Lead sponsor
Rambam Health Care Campus
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2002
Completion date
September 30, 2010
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer